According to guidelines, what is the evidence for using weight loss medications as monotherapy in pediatric obesity?

According to guidelines, what is the evidence for using weight loss medications as monotherapy in pediatric obesity?

• A. There is strong evidence supporting monotherapy
• B. No current evidence supports weight loss medication use as monotherapy
• C. Monotherapy is recommended after lifestyle changes
• D. Monotherapy is preferred over behavioral interventions

Answer: (B)

This item tests whether weight loss medications have evidence as a stand-alone, or monotherapy, treatment in children and teens. In pediatric obesity, the foundation of treatment is intensive lifestyle modification and behavioral support. Medications are considered only as an additional aid to a comprehensive weight-management plan, not as a replacement for lifestyle changes. There isn’t solid evidence showing that using a weight loss drug alone leads to meaningful or durable weight loss in youths, and safety concerns with long-term use in developing children further limit monotherapy use. Therefore, there is no current evidence to support treating pediatric obesity with weight loss medications as monotherapy.

This item tests whether weight loss medications have evidence as a stand-alone, or monotherapy, treatment in children and teens. In pediatric obesity, the foundation of treatment is intensive lifestyle modification and behavioral support. Medications are considered only as an additional aid to a comprehensive weight-management plan, not as a replacement for lifestyle changes. There isn’t solid evidence showing that using a weight loss drug alone leads to meaningful or durable weight loss in youths, and safety concerns with long-term use in developing children further limit monotherapy use. Therefore, there is no current evidence to support treating pediatric obesity with weight loss medications as monotherapy.